Tag Archives: HEXO

MKM Partners Sticks to Their Hold Rating for HEXO (HEXO)

MKM Partners analyst William Kirk reiterated a Hold rating on HEXO (HEXO – Research Report) today and set a price target of C$1.00. The company’s shares closed last Monday at $0.79, close to its 52-week low of $0.35. According to

Analysts Offer Insights on Healthcare Companies: HEXO (NYSE: HEXO) and Knight Therapeutics (Other OTC: KHTRF)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on HEXO (HEXO – Research Report) and Knight Therapeutics (KHTRF – Research Report). HEXO (HEXO) Canaccord Genuity analyst Matt Bottomley maintained a Hold rating

Oppenheimer Reaffirms Their Hold Rating on HEXO (HEXO)

In a report released today, Rupesh Parikh from Oppenheimer maintained a Hold rating on HEXO (HEXO – Research Report). The company’s shares closed last Monday at $0.77, close to its 52-week low of $0.62. According to TipRanks.com, Parikh is a

HEXO (HEXO) Gets a Buy Rating from MKM Partners

MKM Partners analyst William Kirk reiterated a Buy rating on HEXO (HEXO – Research Report) on December 6 and set a price target of C$6.00. The company’s shares closed last Monday at $2.09, close to its 52-week low of $1.56.

CIBC Remains a Hold on HEXO Corp (HEXO)

In a report released yesterday, John Zamparo from CIBC maintained a Hold rating on HEXO Corp (HEXO – Research Report), with a price target of $4.00. The company’s shares closed last Monday at $2.74, close to its 52-week low of

HEXO Corporation (HEXO) Gets a Buy Rating from AltaCorp Captial

On June 14, an analyst has provided a rating update for HEXO Corporation (HEXO – Research Report). Analyst David Kideckel from AltaCorp Captial remains bullish on the stock and has a C$10.40 price target. According to TipRanks.com, Kideckel is ranked